Search the Newsreel

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026

SOPHiA GENETICS announced that it will release its financial results for the second quarter of 2026 before U.S. markets open on Tuesday, August 4, 2026. The company will also host a conference call on the same day at 8:00 a.m. EDT / 2:00 p.m. …

SOPHiA GENETICS sets 8 a.m. webcast for Q2 results call

SOPHiA GENETICS (Nasdaq: SOPH) will release its second quarter 2026 financial results before U.S. markets open on August 4, 2026. The company will host a conference call and live webcast at 8:00 a.m. EDT / 2:00 p.m. CET to discuss these results and its …

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 12-Month High - Time to Buy?

SOPH insider (NASDAQ: SOPH) details planned stock and option-related sales

An insider at SOPHiA GENETICS SA (NASDAQ: SOPH) has filed a Form 144 detailing planned sales of common stock. Jurgi Camblong plans to sell 4,581 shares from an option exercise and 19,800 founder shares, with recent sales already conducted under a Rule 10b5-1 trading …

HC Wainwright Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)

HC Wainwright has initiated coverage on SOPHiA GENETICS (NASDAQ:SOPH) with a "buy" rating and a $12 price target, indicating a potential 104% upside. This positive outlook, shared by BTIG Research, contrasts with a "sell" rating from Weiss Ratings, leading to an overall "Moderate Buy" …

H.C. Wainwright initiates Sophia Genetics stock with buy rating By Investing.com

H.C. Wainwright has initiated coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Buy rating and a $12.00 price target, suggesting over 100% upside. The company operates an AI-driven genomics platform used by hospitals and labs globally, generating recurring revenue. Sophia Genetics recently closed …

SOPHiA GENETICS prices $50M public offering at $4.75 per share

SOPHiA GENETICS has priced a public offering of 10,526,316 shares at $4.75 per share. The offering is expected to raise approximately $50 million in gross proceeds. This financial move aims to secure capital for the company.

SOPHiA GENETICS SA 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:SOPH) 2026-05-07

SOPHiA GENETICS Reports First Quarter 2026 Results

BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8

How The SOPHiA GENETICS (SOPH) Narrative Is Shifting With Recalibrated Growth And Valuation Assumptions

SOPHiA GENETICS (SOPH) Earnings Date and Reports 2026